Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results

被引：0
|
作者：
Armstrong, April W. [1 ]
Lebwohl, Mark [2 ]
Warren, Richard B. [3 ,4 ]
Sofen, Howard [5 ]
Imafuku, Shinichi [6 ]
Ohtsuki, Mamitaro [7 ]
Spelman, Lynda [8 ]
Passeron, Thierry [9 ]
Papp, Kim A. [10 ,11 ]
Kisa, Renata M. [12 ]
Berger, Victoria [12 ,13 ]
Vritzali, Eleni
Hoyt, Kim [12 ]
Colombo, Matthew J. [12 ]
Banerjee, Subhashis [12 ]
Strober, Bruce [14 ]
Thaci, Diamant [15 ]
Blauvelt, Andrew [16 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[5] Univ Calif Los Angeles, Sch Med & Dermatol Res Associates, Los Angeles, CA USA
[6] Fukuoka Univ, Fac Med, Fukuoka, Japan
[7] Jichi Med Univ, Tochigi, Japan
[8] Verac Clin Res, Brisbane, Qld, Australia
[9] Univ Cote Azur, Univ Hosp Nice, Nice, France
[10] Alliance Clin Res & Prob Med Res, Waterloo, ON, Canada
[11] Univ Toronto, Toronto, ON, Canada
[12] Bristol Myers Squibb, Princeton, NJ USA
[13] Bristol Myers Squibb, Sissach, Switzerland
[14] Yale Univ, New Haven, CT USA
[15] Univ Lubeck, Inst & Comprehens Ctr Inflammat Med, Lubeck, Germany
[16] Oregon Med Res Ctr, Portland, OR USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0261
引用
收藏
页码：509 / 511
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of long-term tildrakizumab for plaque psoriasis: 4-year results from reSURFACE 2
    Langley, Richard G.
    Gooderham, Melinda
    Papp, Kim Alexander
    Yamauchi, Paul
    Thaci, Diamant
    Parno, Jeff
    Mendelsohn, Alan M.
    Rozzo, Stephen J.
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB163 - AB163
  • [32] Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials
    Korman, Neil J.
    Warren, Richard B.
    Bagel, Jerry
    Armstrong, April W.
    Gooderham, Melinda
    Strober, Bruce
    Thaci, Diamant
    Morita, Akimichi
    Imafuku, Shinichi
    Foley, Peter
    Sofen, Howard
    Zheng, Min
    Hippeli, Lauren
    Kisa, Renata M.
    Banerjee, Subhashis
    Blauvelt, Andrew
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [33] Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials
    Morita, Akimichi
    Imafuku, Shinichi
    Tada, Yayoi
    Okubo, Yukari
    Habiro, Katsuyoshi
    Tsuritani, Katsuki
    Banerjee, Subhashis
    Hoyt, Kim
    Kisa, Renata M.
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2025,
  • [34] PONATINIB EFFICACY AND SAFETY IN HEAVILY PRETREATED LEUKEMIA PATIENTS: 3-YEAR RESULTS OF THE PACE TRIAL
    Cortes, J.
    Kim, D. W.
    Pinilla-Ibarz, J.
    le Coutre, P. D.
    Paquette, R.
    Chuah, C.
    Nicolini, F. E.
    Apperley, J. F.
    Khoury, H. J.
    Talpaz, M.
    DiPersio, J. F.
    DeAngelo, D. J.
    Abruzzese, E.
    Rea, D.
    Baccarani, M.
    Mueller, M. C.
    Gambacorti-Passerini, C.
    Lustgarten, S.
    Rivera, V. M.
    Clackson, T.
    Haluska, F. G.
    Guilhot, F.
    Deininger, M. W.
    Hochhaus, A.
    Hughes, T. P.
    Shah, N. P.
    Kantarjian, H. M.
    HAEMATOLOGICA, 2015, 100 : 64 - 64
  • [35] Deucravacitinib in Plaque Psoriasis: 4-Year Efficacy Results by Prior Biologic Treatment in the Phase 3 POETYK PSO-1, PSO-2, and Long-Term ExtensionTrials
    Warren, Richard
    Armstrong, April W.
    Imafuku, Shinichi
    Morita, Akimichi
    Paul, Carle
    Augustin, Matthias
    Passeron, Thierry
    Kircik, Leon
    Vritzali, Eleni
    Scharnitz, Thomas
    Schroeder, Georgene
    Banerjee, Subhashis
    Strober, Bruce
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2310 - 2312
  • [36] Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials
    Igarashi, Atsuyuki
    Tsuji, Gaku
    Fukasawa, Shuichi
    Murata, Ryusei
    Yamane, Satoshi
    JOURNAL OF DERMATOLOGY, 2024, 51 (10): : 1269 - 1278
  • [37] Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and POETYK PSO-LTE Trials
    Lebwohl, Mark
    Warren, Richard B.
    Kircik, Leon
    Colston, Elizabeth
    Hippeli, Lauren
    Napoli, Andrew
    Kisa, Renata M.
    Banerjee, Subhashis
    Menter, Alan
    Thaci, Diamant
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB35 - AB35
  • [38] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [39] Tazarotene gel: Efficacy and safety in plaque psoriasis - Discussion
    SchaeferKorting
    Chandraratna
    Orfanos, C
    Greaves, M
    Duvic
    Aal, A
    Marks
    Fattah, A
    Munroe, C
    Weinstein
    Freeman, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (02) : S39 - S40
  • [40] Exploring the Efficacy, Safety, and Clinical Implications of Deucravacitinib in East Asians with Psoriasis: A Narrative Review
    Bang, Chul-Hwan
    Park, Chul-Jong
    Kim, Yoon-Seob
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
12345